What are the indications, dosing, contraindications, side effects, and alternatives for sildenafil (Slinadafil)?

Sildenafil: Clinical Overview

Indications

Sildenafil is FDA-approved for two distinct indications: erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). 1

For Erectile Dysfunction:

• Treatment of ED across all etiologies (organic, psychogenic, mixed) 2
• Effective in men with diabetes, cardiovascular disease, depression, spinal cord injury, post-prostatectomy, and other comorbidities 3

For Pulmonary Arterial Hypertension:

• WHO Group I PAH in adults to improve exercise ability and delay clinical worsening 1
• Persistent pulmonary hypertension of the newborn (PPHN), though pediatric dosing is under marketing exclusivity 1, 4

---

Dosing

Erectile Dysfunction:

Start with 50 mg taken approximately 1 hour before sexual activity, no more than once daily. 2, 5

• Titration: Can increase to 100 mg or decrease to 25 mg based on efficacy and tolerability 2, 5
• Dose adjustments needed for:
  • Age ≥65 years: Consider starting at 25 mg 5
  • Hepatic or renal impairment: Start at 25 mg 5
  • Concurrent CYP3A4 inhibitors (ritonavir, ketoconazole, erythromycin, cimetidine): Start at 25 mg 5

The 2025 EAU guidelines confirm that all four PDE5 inhibitors (sildenafil, vardenafil, tadalafil, avanafil) are equally effective, with selection based on intercourse frequency and patient preference 2. Sildenafil's shorter duration of action (3-5 hours) makes it suitable for on-demand use 5.

Pulmonary Arterial Hypertension:

The FDA-approved dose is 20 mg three times daily (every 8 hours). 1

---

Contraindications

Sildenafil is absolutely contraindicated in three situations: 1

1. Concurrent use of organic nitrates (regularly or intermittently) due to severe hypotension risk
2. Concurrent use of riociguat (guanylate cyclase stimulator) due to potentiated hypotensive effects
3. Known hypersensitivity to sildenafil or any tablet component (anaphylaxis has been reported)

---

Side Effects

Common Adverse Effects (>2%):

• Headache (most common) 3, 5, 6
• Flushing 3, 5
• Dyspepsia 3, 5
• Nasal congestion 5, 6
• Abnormal vision (color perception changes due to PDE6 inhibition) 5, 6
• Dizziness 6

Serious Adverse Effects:

• Hypotension: Particularly in patients on antihypertensives, with resting BP <90/50, fluid depletion, or severe left ventricular outflow obstruction 1
• NAION (non-arteritic anterior ischemic optic neuropathy): Sudden vision loss; advise patients to seek immediate medical attention 1
• Sudden hearing loss: Rare but requires immediate evaluation 1
• Epistaxis: 13% incidence in PAH patients with connective tissue disease, higher with concurrent vitamin K antagonists 1
• Pulmonary edema: If occurs, consider pulmonary veno-occlusive disease (PVOD) 1

Special Populations:

• Cardiovascular events: Postmarketing surveillance revealed deaths primarily in men with pre-existing heart disease, nitrate use, or poor physical health 6
• Sickle cell disease: May cause serious vaso-occlusive crises in PH patients 1

---

Alternatives

For Erectile Dysfunction:

Other PDE5 inhibitors are equally effective first-line options: 2, 3

1. Vardenafil: Similar efficacy to sildenafil; does not affect color perception (no PDE6 inhibition) 7
2. Tadalafil: Longer duration of action (up to 36 hours); may be preferred for spontaneity 7
3. Avanafil: Fastest onset of action 2

Second-line therapies for PDE5 inhibitor non-responders: 2

• Intracavernosal injections (alprostadil)
• Intraurethral alprostadil
• Vacuum erection devices (VED)
• Low-intensity shockwave therapy (LI-SWT)
• Combination therapy: PDE5i + testosterone (in hypogonadal men) 2, 3

Third-line therapy:

• Penile prosthesis implantation 2

For Pulmonary Arterial Hypertension:

Alternatives include other pulmonary vasodilators:

• Endothelin receptor antagonists (bosentan, ambrisentan)
• Prostacyclin analogs (epoprostenol, treprostinil)
• Riociguat (guanylate cyclase stimulator) - cannot be combined with sildenafil 1

---

Key Clinical Pearls

Optimizing Sildenafil Use in ED:

Many "non-responders" are actually using the medication incorrectly. 2 Verify:

• Timing: Take 30-60 minutes before sexual activity (not immediately before) 5
• Sexual stimulation: Sildenafil requires sexual arousal to work 6
• Food: High-fat meals delay absorption 5
• Adequate trial: At least 4-6 attempts at maximum tolerated dose before declaring failure 2

Cardiovascular Safety:

Sildenafil is safe in men with stable coronary artery disease provided they are not on nitrates. 7, 5 The 2025 EAU guidelines recommend cardiovascular risk stratification using ACC/AHA atherosclerotic CVD risk assessment for borderline/intermediate-risk patients 2.

Combination Therapy:

For hypogonadal men with ED not responding to PDE5 inhibitors alone, adding testosterone therapy may restore effectiveness 2. However, evidence quality is low 3.

Formulation Considerations:

A 2026 study showed sildenafil oral suspension has faster onset (30 vs 60 minutes) and higher satisfaction in men ≤65 years compared to tablets, with similar efficacy and safety 8.